Villavicencio, Alan T. MD; Burneikiene, Sigita MD; Pashman, Robert MD; Johnson, J. Patrick MD
Dr. Villavicencio is Director of Research and Development, and Dr. Burneikiene is a Clinical Research Physician, Boulder Neurosurgical Associates, 1155 Alpine Avenue, Suite 320, Boulder, CO 80304; E-mail: [email protected]; Dr. Johnson is Director, Institute for Spinal Disorders, Cedars Sinai Medical Center, Los Angeles, CA, and Dr. Pashman is Director of Scoliosis and Spinal Deformity, Cedars Sinai Medical Center, Los Angeles, CA.
Dr. Villavicencio has disclosed that he is/was the recipient of grant/research funding from Medtronic Sofamor Danek (as principal investigator in the Maverick Artificial Disc Replacement Trial). Dr. Johnson has disclosed that he is/was a consultant/advisor to SpineWave, Alphatec, Flexuspine, and Johnson & Johnson and is/was a stock shareholder of SpineWave, Alphatec, Flexuspine, and Pioneer. Dr. Burneikiene and Dr. Pashman have disclosed that they have no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity.
The authors have disclosed that the use of the artificial discs as described in this article for the treatment of cervical disorders has not been approved by the U.S. Food and Drug Administration.
Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity.
Category: Spine
doi: 10.1097/01.CNE.0000271889.75370.bb
